Here are the top health news for the day:Dr Harsh Vardhan's retirement from politics: Returning to his roots in ENTAfter a long political career of 30 years, the former Union Health Minister Dr. Harsh Vardhan has announced his decision to quit electoral politics.In an X post, Dr Harsh Vardhan mentioned that he has promises to keep and announced his decision to go back to his ENT Clinic at...
Here are the top health news for the day:
Dr Harsh Vardhan's retirement from politics: Returning to his roots in ENT
After a long political career of 30 years, the former Union Health Minister Dr. Harsh Vardhan has announced his decision to quit electoral politics.
In an X post, Dr Harsh Vardhan mentioned that he has promises to keep and announced his decision to go back to his ENT Clinic at Krishna Nagar. He further mentioned that he would continue to pursue his work against tobacco and substance abuse, against climate change as well as teaching simple and sustainable lifestyles.
For more information click on the link below:
In a significant legal development in New Delhi, the Delhi High Court issued an interim order restraining Mumbai-based Elder Projects from threatening Antex Pharma over the 'ELDER' and 'ELDERVIT' trademarks. Antex Pharma argued that their extensive use of these trademarks for pharmaceutical products has garnered significant goodwill, while Elder Projects allegedly made baseless legal threats to assert rights over them. The court's decision reflects a cautious approach, balancing the protection of Antex Pharma from intimidation tactics with the recognition that ownership of the 'ELDER' trademark belongs to Elder Pharmaceuticals Ltd., as confirmed by a 2019 judgment. This ruling nullifies Elder Projects' claims. The interim order not only provides temporary relief to Antex Pharma but also signals the court's acknowledgment of the importance of fair competition and protecting established trademarks in the pharmaceutical industry. As the case progresses, it will have implications for trademark law and corporate practices in India's pharmaceutical sector, showcasing the judiciary's role in navigating trademark disputes.
Participating in 'ANI Dialogues - Navigating India's Health Sector' here, Dr Srinivas said AI complements and supplements efforts and allows scalability and filtering at a faster pace.
For more information click on the link below:
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd